CA1212645A - Acide hyaluronique produit par des bacteries - Google Patents

Acide hyaluronique produit par des bacteries

Info

Publication number
CA1212645A
CA1212645A CA000440977A CA440977A CA1212645A CA 1212645 A CA1212645 A CA 1212645A CA 000440977 A CA000440977 A CA 000440977A CA 440977 A CA440977 A CA 440977A CA 1212645 A CA1212645 A CA 1212645A
Authority
CA
Canada
Prior art keywords
bacteria
acid
hyaluronic acid
broth
separating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000440977A
Other languages
English (en)
Inventor
Kipling Thacker
James W. Bracke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diagnostic Inc
Original Assignee
Diagnostic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diagnostic Inc filed Critical Diagnostic Inc
Application granted granted Critical
Publication of CA1212645A publication Critical patent/CA1212645A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/801—Anerobic cultivation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/885—Streptococcus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
CA000440977A 1983-02-18 1983-11-10 Acide hyaluronique produit par des bacteries Expired CA1212645A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US467,925 1983-02-18
US06/467,925 US4517295A (en) 1983-02-18 1983-02-18 Hyaluronic acid from bacterial culture

Publications (1)

Publication Number Publication Date
CA1212645A true CA1212645A (fr) 1986-10-14

Family

ID=23857716

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000440977A Expired CA1212645A (fr) 1983-02-18 1983-11-10 Acide hyaluronique produit par des bacteries

Country Status (14)

Country Link
US (1) US4517295A (fr)
EP (1) EP0137786B1 (fr)
JP (1) JPS60500597A (fr)
CN (1) CN85103674A (fr)
AT (1) ATE40407T1 (fr)
AU (1) AU556730B2 (fr)
CA (1) CA1212645A (fr)
DE (1) DE3379056D1 (fr)
DK (1) DK173681B1 (fr)
FI (1) FI79346C (fr)
IL (1) IL69900A (fr)
IT (1) IT1172379B (fr)
NO (1) NO160146C (fr)
WO (1) WO1984003302A1 (fr)

Families Citing this family (113)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166331A (en) * 1983-10-10 1992-11-24 Fidia, S.P.A. Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same
IT1212892B (it) * 1983-10-11 1989-11-30 Della Valle Francesco Acido ialuronico ottenuto per mezzodi filtrazione molecolare sprovvisto di attivita' infiammatoria e sua utilizzazione terapeutica
US4638056A (en) * 1983-07-22 1987-01-20 Cilco, Inc. Opthalmic wafer
NO161573C (no) * 1983-11-25 1989-08-30 Miles Inc Fremgangsmaate til fremstilling av hyaluronsyre.
US5093487A (en) * 1986-01-06 1992-03-03 Mobay Corporation Low viscosity high molecular weight filter sterilizable hyaluronic acid
US5316926A (en) * 1983-11-25 1994-05-31 Miles Inc. Method for the microbiological production of non-antigenic hyaluronic acid
JPS60251898A (ja) * 1984-05-25 1985-12-12 Shiseido Co Ltd 醗酵法によるヒアルロン酸の製造方法
US4780414A (en) * 1985-01-18 1988-10-25 Bio-Technology General Corp. Method of producing high molecular weight sodium hyallronate by fermentation of streptococcus
US4713448A (en) * 1985-03-12 1987-12-15 Biomatrix, Inc. Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues
US5099013A (en) * 1985-03-12 1992-03-24 Biomatrix, Inc, Hylan preparation and method of recovery thereof from animal tissues
SE8501723L (sv) * 1985-04-09 1986-10-10 Pharmacia Ab Preparation att anvendas vid behandling av ledinflammation
WO1986006728A1 (fr) * 1985-05-09 1986-11-20 Hill David Cullis Preparation d'acide hyaluronique
US5202431A (en) * 1985-07-08 1993-04-13 Fidia, S.P.A. Partial esters of hyaluronic acid
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
IN166447B (fr) * 1985-11-27 1990-05-12 Ethicon Inc
US4808576A (en) * 1986-04-28 1989-02-28 Mobay Corporation Remote administration of hyaluronic acid to mammals
JPH072117B2 (ja) * 1986-10-09 1995-01-18 三菱レイヨン株式会社 ヒアルロン酸の製造法
US5079236A (en) * 1987-05-27 1992-01-07 Hyal Pharmaceutical Corporation Pure, sterile, pyrogen-free hyaluronic acid formulations their methods of preparation and methods of use
US4946780A (en) * 1988-10-12 1990-08-07 Denkl Kagaku Kogyo Kabushiki Kaisha Method for producing sodium hyaluronate by fermentation method
US4897349A (en) * 1989-04-28 1990-01-30 Medchem Products, Inc. Biosynthesis of hyaluronic acid
US6271216B1 (en) 1989-07-24 2001-08-07 Allergan Stable solution of hyaluronate in a balanced salt medium
US5015577A (en) * 1989-08-29 1991-05-14 Board Of Regents, The University Of Texas System DNA encoding hyaluronate synthase
US5910489A (en) * 1990-09-18 1999-06-08 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
US5990096A (en) * 1990-09-18 1999-11-23 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5824658A (en) * 1990-09-18 1998-10-20 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
CA2061703C (fr) * 1992-02-20 2002-07-02 Rudolf E. Falk Compositions renfermant de l'acide hyaluronique
GB9024223D0 (en) * 1990-11-07 1990-12-19 Fermentech Ltd Production of hyaluronic acid
US5492936A (en) * 1990-11-30 1996-02-20 Allergan, Inc. Bimodal molecular weight hyaluronate formulations and methods for using same
US5705178A (en) * 1991-05-31 1998-01-06 Gliatech, Inc. Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
US5605938A (en) * 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
US5234914A (en) * 1991-06-11 1993-08-10 Patent Biopharmaceutics, Inc. Methods of treating hemorrhoids and anorecial disease
US5792753A (en) * 1991-07-03 1998-08-11 Hyal Pharmaceutical Corporation Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs
US5977088A (en) * 1991-07-03 1999-11-02 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US6103704A (en) * 1991-07-03 2000-08-15 Hyal Pharmaceutical Corporation Therapeutic methods using hyaluronic acid
US6218373B1 (en) 1992-02-20 2001-04-17 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5767106A (en) * 1992-02-21 1998-06-16 Hyal Pharmaceutical Corporation Treatment of disease and conditions associated with macrophage infiltration
US5226359A (en) * 1992-03-10 1993-07-13 Vermeer Manufacturing Company Bale size indicator
US5550112A (en) * 1992-12-30 1996-08-27 Patent Biopharmaceutics, Inc. Hyaluronic acid-urea pharmaceutical compositions and uses
US5681825A (en) * 1993-03-15 1997-10-28 Lindqvist; Bengt Surgical method
IT1263393B (it) * 1993-07-30 1996-08-05 Fidia Advanced Biopolymers Srl Processo per la preparazione e purificazione di acido ialuronico ad alto peso molecolare
US6551618B2 (en) 1994-03-15 2003-04-22 University Of Birmingham Compositions and methods for delivery of agents for neuronal regeneration and survival
US5962477A (en) * 1994-04-12 1999-10-05 Adolor Corporation Screening methods for cytokine inhibitors
US6190691B1 (en) 1994-04-12 2001-02-20 Adolor Corporation Methods for treating inflammatory conditions
SE9401806D0 (sv) 1994-05-26 1994-05-26 Pharmacia Ab Method and means for the production of hyaluronic acid
US7091008B1 (en) 1994-07-01 2006-08-15 The Board Of Regents Of The University Of Oklahoma Hyaluronan synthase genes and expression thereof in Bacillus hosts
US6455304B1 (en) * 1994-07-01 2002-09-24 The Board Of Regents Of The University Of Oklahoma Hyaluronate synthase gene and uses thereof
US6951743B2 (en) 1997-10-31 2005-10-04 University Of Oklahoma Board Of Regents Hyaluronan synthase genes and expression thereof in bacillus hosts
IT1274984B (it) * 1994-12-09 1997-07-29 Technopharma Sa Soluzioni viscosizzate con ialuronato di sodio per l'uso come fluido maschera nella fotocheratectomia terapeutica mediante laser a accimeri
US6573282B1 (en) 1995-09-12 2003-06-03 Adolor Corporation Peripherally active anti-hyperalgesic opiates
US5849761A (en) * 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
DE69732308T2 (de) * 1996-09-27 2005-06-02 Jagotec Ag Arzneistoffverabreichungssystem mit hyaluronsäure
US6309670B1 (en) 1997-01-15 2001-10-30 Orquest, Inc. Collagen-polysaccharide matrix for treatment of bone tumors
US5866165A (en) * 1997-01-15 1999-02-02 Orquest, Inc. Collagen-polysaccharide matrix for bone and cartilage repair
US6869938B1 (en) 1997-06-17 2005-03-22 Fziomed, Inc. Compositions of polyacids and polyethers and methods for their use in reducing adhesions
US5906997A (en) * 1997-06-17 1999-05-25 Fzio Med, Inc. Bioresorbable compositions of carboxypolysaccharide polyether intermacromolecular complexes and methods for their use in reducing surgical adhesions
US7192984B2 (en) 1997-06-17 2007-03-20 Fziomed, Inc. Compositions of polyacids and polyethers and methods for their use as dermal fillers
CN101113436B (zh) * 1997-10-31 2013-02-06 俄克拉何马大学董事会 透明质酸合酶基因及其应用
DE69828193T2 (de) * 1997-10-31 2005-12-01 The Board Of Regents Of The University Of Oklahoma, Norman Hyaluronan synthase gen und seine verwendung
US20060188966A1 (en) * 1998-04-02 2006-08-24 Deangelis Paul L Natural, chimeric and hybrid glycosaminoglycan polymers and methods of making and using same
US7223571B2 (en) * 1998-04-02 2007-05-29 The Board Of Regents Of The Universtiy Of Oklahoma Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same
US6987023B2 (en) * 1998-04-02 2006-01-17 The Board Of Regents Of The University Of Oklahoma DNA encoding hyaluronan synthase from Pasteurella multocida and methods of use
US20080108110A1 (en) * 1998-04-02 2008-05-08 Deangelis Paul L Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same
US6630457B1 (en) * 1998-09-18 2003-10-07 Orthogene Llc Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same
US7094581B2 (en) * 1998-10-26 2006-08-22 The Board Of Regents Of The University Of Oklahoma Hyaluronan synthases and methods of making and using same
CH692919A5 (fr) * 1999-01-28 2002-12-13 Trb Chemedica S A Procédé de purification de l'acide hyaluronique à poids moléculaire élevé.
EP1207828B1 (fr) 1999-07-28 2004-09-29 United States Surgical Corporation Barriere anti-adhesion a base d'acide hyaluronique
US6566345B2 (en) 2000-04-28 2003-05-20 Fziomed, Inc. Polyacid/polyalkylene oxide foams and gels and methods for their delivery
US20050287638A1 (en) * 2000-04-25 2005-12-29 Weigel Paul H Hyaluronan receptor for endocytosis, variants thereof, and methods of making and using same
ATE420653T1 (de) 2001-02-23 2009-01-15 Scripps Research Inst Von tryptophanyl-trna-synthetase stammende polypeptide zur regulierung der angiogenese
US20070020737A1 (en) * 2001-12-03 2007-01-25 Pummill Philip E Hyaluronan synthases and methods of making and using same
KR101023049B1 (ko) * 2002-06-20 2011-03-24 노보자임스 바이오파마 디케이 에이/에스 2가 염을 사용한 응집 방법
US20040126853A1 (en) * 2002-06-20 2004-07-01 Novozymes A/S Flocculation with divalent salt
CN103638040A (zh) * 2002-07-03 2014-03-19 派瑞克科学公司 透明质酸组合物以及使用方法
WO2004016771A1 (fr) * 2002-08-19 2004-02-26 Kolon Ind. Inc. Micro-organisme produisant de l'acide hyaluronique et procede de purification de l'acide hyaluronique
KR100829086B1 (ko) * 2002-08-19 2008-05-16 코오롱생명과학 주식회사 히아루론산 및 그의 염 정제방법
KR100472007B1 (ko) * 2002-08-19 2005-03-10 주식회사 코오롱 히아루론산 생산 균주 및 상기 균주를 이용한 히아루론산 생산방법
US20080063677A1 (en) * 2004-03-10 2008-03-13 New Life Resources, Llc Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations
US20040180025A1 (en) * 2003-03-12 2004-09-16 New Life Resources, Llc Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations
US6946551B2 (en) * 2003-03-12 2005-09-20 New Life Resources, Llc Preparation of hyaluronic acid from eggshell membrane
WO2005077304A1 (fr) 2004-02-06 2005-08-25 Georgia Tech Research Corporation Dispositif biocompatible porteur
WO2005077013A2 (fr) 2004-02-06 2005-08-25 Georgia Tech Research Corporation Implantation cellulaire a adhesion de surface
US8580315B2 (en) * 2004-03-10 2013-11-12 Esm Technologies, Llc Anti-inflammatory activity of eggshell membrane and processed eggshell membrane preparations
US7002007B2 (en) * 2004-05-28 2006-02-21 Calcigen Corporation Production of high molecular weight hyaluronates
US20060040895A1 (en) * 2004-08-19 2006-02-23 Kipling Thacker Aesthetic use of hyaluronan
US8377125B2 (en) 2006-04-05 2013-02-19 Anew Optics, Inc. Intraocular lens with accommodation
ITMI20061668A1 (it) * 2006-09-01 2008-03-02 Schiena Michele Giuseppe Di Composizione a base di acido ialuronico e suoi sali per il trattamento di lesioni epiteliali
AU2008210557B2 (en) 2007-01-30 2013-08-01 Cypress Pharmaceutical, Inc. Hyaluronate compositions
FR2919185B1 (fr) * 2007-07-23 2010-09-10 Ard Sa Utilisation d'acide hyaluronique pour la preparation de compositions destinees a l'amelioration notamment de l'etat des muqueuses
US20100290989A1 (en) * 2007-10-12 2010-11-18 London Health Sciences Centre Research Inc. Compositions affecting hyaluronic acid mediated activity
US20110130473A1 (en) 2007-11-13 2011-06-02 Bio-Technology General (Israel) Ltd. Dilute filtration sterilization process for viscoelastic biopolymers
US8480734B2 (en) 2007-12-27 2013-07-09 Anew Optics, Inc. Intraocular lens with accommodation
US8624077B2 (en) 2008-10-02 2014-01-07 L.R.R.&D. Ltd. Interface layer wound dressing
US10010405B2 (en) 2008-11-26 2018-07-03 Anew Aol Technologies, Inc. Haptic devices for intraocular lens
WO2010062972A1 (fr) * 2008-11-26 2010-06-03 Anew Optics, Inc. Optique de lentille intraoculaire
CA2744859C (fr) 2008-11-26 2015-11-24 Anew Optics, Inc. Dispositifs haptiques comportant un ruban annulaire pour lentille intraoculaire
US20110191086A1 (en) * 2010-02-04 2011-08-04 Anew Optics, Inc. Model of accommodative intraocular lens
CN102533902A (zh) * 2010-12-22 2012-07-04 桐乡恒基生物有限公司 一种非动物蛋白源透明质酸钠制备方法
ITMI20110033A1 (it) 2011-01-17 2012-07-18 Biofarmitalia Spa Composizione terapeutica mucoadesiva a base di acido ialuronico per la prevenzione e terapia di lesioni epiteliali, delle mucose del corpo umano
EP2757964B1 (fr) 2011-05-26 2016-05-04 Cartiva, Inc. Implant d'articulation conique et outils associés
CN102495053A (zh) * 2011-12-06 2012-06-13 上海景峰制药有限公司 一种玻璃酸钠中蛋白质的检测方法
SG10201604810UA (en) 2012-02-07 2016-08-30 Global Bio Therapeutics Inc Compartmentalized method of nucleic acid delivery and compositions and uses thereof
ES2837626T3 (es) 2013-07-10 2021-07-01 Matrix Biology Inst Composiciones de hialuronano con alta elasticidad y usos de las mismas
MX2016001667A (es) 2013-08-08 2016-11-07 Global Bio Therapeutics Inc Dispositivo de sujecion para procedimientos minimamente invasivos y usos del mismo.
ITMI20131654A1 (it) * 2013-10-07 2015-04-08 Rosa Mario De Downstream di purificazione di acido ialuronico da brodi di coltura microbici
US9907663B2 (en) 2015-03-31 2018-03-06 Cartiva, Inc. Hydrogel implants with porous materials and methods
EP3892241A1 (fr) 2015-03-31 2021-10-13 Cartiva, Inc. Foret pour implant carpométacarpien
EP3282961A4 (fr) 2015-04-14 2018-12-05 Cartiva, Inc. Outillage pour création d'une ouverture conique dans le tissu et procédés associés
CA2896038C (fr) 2015-07-03 2022-08-09 Glycobiosciences Inc. Compositions de matrice polymere renfermant une concentration elevee d'hyalluonate de sodium bio-fermente et leurs utilisations
RU2727809C2 (ru) 2015-09-24 2020-07-24 Матрикс Байолэджи Инститьют Композиции гиалуроновой кислоты с высокоэластичными свойствами и способы их применения
WO2019158541A1 (fr) 2018-02-14 2019-08-22 Frieslandcampina Nederland B.V. Compositions nutritionnelles pour soutien musculo-squelettique pour athlètes
KR102249438B1 (ko) * 2020-09-25 2021-05-07 주식회사 칸젠 히알루론산 생산 균주 및 이를 이용한 히알루론산의 생산방법
RU2765951C1 (ru) * 2021-05-14 2022-02-07 Общество с ограниченной ответственностью "АВЕО" Способ очистки гиалуроната от эндотоксинов
CN113854451A (zh) * 2021-09-07 2021-12-31 蓝海细胞(北京)生物科技有限公司 一种改善肤质的透明质酸钠复合肽饮品的加工工艺

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2975104A (en) * 1959-05-21 1961-03-14 American Home Prod Medium and method for producing and isolating hyaluronic acid
US4141973A (en) * 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
JPS53113090A (en) * 1977-03-09 1978-10-03 Cpc International Inc Production of high viscous acidic polysaccharide by microorganism
US4303676A (en) * 1980-03-21 1981-12-01 Balazs Endre A Hyaluronate based compositions and cosmetic formulations containing same
CA1177003A (fr) * 1980-07-08 1984-10-30 Peter S.J. Cheetham Procede de production d'ethanol par des bacteries
US4328803B1 (en) * 1980-10-20 1994-01-11 Opthalmic Systems, Inc. Opthalmological procedures
SU950735A1 (ru) * 1980-10-28 1982-08-15 Саратовский Ордена Трудового Красного Знамени Государственный Университет Им.Н.Г.Чернышевского Способ получени гиалуроновой кислоты
JPS57183707A (en) * 1981-05-02 1982-11-12 Shiseido Co Ltd Cosmetic
JPS57212300A (en) * 1981-06-22 1982-12-27 Pola Kasei Kogyo Kk Detergent composition
JPS5856692A (ja) * 1981-09-26 1983-04-04 Shiseido Co Ltd ヒアルロン酸の製造方法
JPS5857319A (ja) * 1981-09-30 1983-04-05 Green Cross Corp:The 高粘性ヒアルロン酸製剤

Also Published As

Publication number Publication date
NO160146C (no) 1989-03-15
IT8349510A0 (it) 1983-12-15
NO160146B (no) 1988-12-05
JPS60500597A (ja) 1985-05-02
ATE40407T1 (de) 1989-02-15
AU556730B2 (en) 1986-11-13
US4517295A (en) 1985-05-14
AU2076883A (en) 1984-09-10
FI79346C (fi) 1989-12-11
EP0137786A4 (fr) 1986-01-07
IT1172379B (it) 1987-06-18
FI844091L (fi) 1984-10-17
IL69900A0 (en) 1984-01-31
NO844112L (no) 1984-10-15
DE3379056D1 (en) 1989-03-02
EP0137786B1 (fr) 1989-01-25
FI844091A0 (fi) 1984-10-17
FI79346B (fi) 1989-08-31
DK173681B1 (da) 2001-06-11
EP0137786A1 (fr) 1985-04-24
CN85103674A (zh) 1986-11-12
DK499284D0 (da) 1984-10-18
WO1984003302A1 (fr) 1984-08-30
DK499284A (da) 1984-10-18
IL69900A (en) 1987-02-27

Similar Documents

Publication Publication Date Title
CA1212645A (fr) Acide hyaluronique produit par des bacteries
US5316926A (en) Method for the microbiological production of non-antigenic hyaluronic acid
CA1270219A (fr) Acide hyaluronique ultrapur et methode de preparation
EP0211037B1 (fr) PROCEDE DE PRODUCTION D'HYALURONATE DE SODIUM DE POIDS MOLECULAIRE ELEVE PAR FERMENTATION DE $i(STREPTOCOCCUS)
US4784990A (en) High molecular weight sodium hyaluronate
US4801539A (en) Fermentation method for producing hyaluronic acid
US5071751A (en) Process for preparing hyaluronic acid
EP0041897B1 (fr) Antigène de polysaccharide de streptocoque et vaccins
CA2360343C (fr) Procede de purification d'acide hyaluronique a poids moleculaire eleve
US4123520A (en) Method for preparing high molecular weight meningococcal Group C vaccine
EP0624651B1 (fr) Gomme de xanthane de perméates de lait et autres produits filtrés de lait
US4235994A (en) High molecular weight meningococcal group C vaccine and method for preparation thereof
CA1328841C (fr) Methode de production microbiologique d'acide hyaluronique non antigenique
JP3632197B2 (ja) 高分子量ヒアルロン酸もしくはその塩の製造法
Jacobson Bracke et a1.
JPH0549491A (ja) 微細藻類から多糖類を生産する方法
KR880001949B1 (ko) 히아론산의 제조방법
JPH062073B2 (ja) ヒアルロン酸の製造法
JPH0630604B2 (ja) ヒアルロン酸の製造法
JPH046356B2 (fr)
NL8302880A (nl) Carcinostaticum en werkwijze ter verkrijging daarvan.
JPS63273471A (ja) Ａｔ−２５菌

Legal Events

Date Code Title Description
MKEX Expiry